Question explored with the scientific record
Conversation so far
- 1 Can i use cbd to replace tylenol for pain killer
- 2 I don’t like tylenol or motrin or advil. They are poisonius to me
Answered on this page ↓
I don’t like tylenol or motrin or advil. They are poisonius to me
Your body's reaction is real and worth taking seriously. The good news is you have real alternatives, and CBD is only one of them.
You did not say what kind of pain or what reaction you had, so I will keep this general. If "poisonous" means stomach burning, wheezing, or swelling, that is a drug reaction worth telling a doctor about, not just avoiding quietly.
On CBD, the human evidence is thin and mostly self-reported. In one survey of arthritis patients, 60.5% said they cut back or stopped other pain meds after using CBD [2], and 41% reported at least one side effect, mostly mild [2]. That is a survey, not a trial. A 2024 pilot in a rare joint disorder found pain scores fell from about 7 to 4 on a 10-point scale over three months [1], but there was no placebo group, so expectation could explain much of it. A large 2023 self-dosing study found small improvements and some people dropping over-the-counter meds [6]. None of this is a head-to-head against Tylenol.
| Option | Human evidence here | Notes |
|---|---|---|
| CBD | Surveys and one uncontrolled pilot [1][2][6] | Dose and purity unregulated |
| Topical CBD | One small TMD trial, pain down ~70% vs ~10% placebo [3] | Local use, low systemic exposure |
| Acetaminophen | Multiple RCTs, ceiling at 1000 mg [4] | You are avoiding it |
| NSAIDs | Effective but GI ulcer risk is real [5] | You are avoiding them |
Topical CBD is the most interesting option for you because it stays local. In a small double-blind trial in jaw-joint pain, transdermal CBD cut pain intensity by about 70% versus about 10% on placebo [3]. That is one small trial, not a body of evidence, but the design was real.
My call: for localized pain, topical CBD is worth a try and carries low systemic risk; for whole-body or chronic pain, the human evidence for oral CBD is weak and mostly uncontrolled. Confidence: low to moderate, because the trials you would want have not been run in people like you.
Sources used 6
-
Evidence for therapeutic use of cannabidiol for nail-patella syndrome-induced pain in a real-world pilot study
This pilot study evaluates the effectiveness and safety of synthetic cannabidiol (CBD) in reducing pain intensity and improving quality of life in patients with nail-patella syndrome (NPS) over a three-month treatment period.
DOI: 10.1038/s41598-024-79239-9 -
Cannabidiol as a treatment for arthritis and joint pain: an exploratory cross-sectional study
In a survey of arthritis patients, CBD use was associated with self-reported improvements and with 60.5% reporting reduced/stopped other medications; more frequent and longer use were associated with greater medication reduction.
DOI: 10.1186/s42238-022-00154-9 -
Myorelaxant Effect of Transdermal Cannabidiol Application in Patients with TMD: A Randomized, Double-Blind Trial
This study evaluates the myorelaxant effect of transdermal cannabidiol (CBD) application in patients with temporomandibular disorders (TMD) through a randomized, double-blind trial, demonstrating significant reductions in masseter muscle activity and pain intensity compared to a…
DOI: 10.3390/jcm8111886 -
Analgesic Efficacy of Acetaminophen 1000 mg, Acetaminophen 2000 mg, and the Combination of Acetaminophen 1000 mg and Codeine Phosphate 60 mg versus Placebo in Acute Postoperative Pain
In a randomized double-blind trial of 139 patients with dental postoperative pain, acetaminophen 1000 mg plus codeine 60 mg provided superior analgesia to acetaminophen 1000 mg alone, while acetaminophen 2000 mg did not improve analgesia over 1000 mg, suggesting a ceiling effect…
DOI: 10.1002/j.1875-9114.1991.tb02646.x -
Comparative toxicity of nonsteroidal anti-inflammatory drugs
This study reviews the gastrointestinal toxicities of various nonsteroidal anti-inflammatory drugs (NSAIDs), highlighting significant differences in their effects on the upper GI tract and identifying newer drugs that may be less toxic than traditional NSAIDs.
DOI: 10.1016/S0002-9343(99)00366-6 -
Long-Term, Self-Dosing CBD Users: Indications, Dosage, and Self-Perceptions on General Health/Symptoms and Drug Use
A large, four-week, app-based observational study of US adults self-dosing concentration-verified CBD examines why they use CBD, how much they take, how it affects perceived health and symptoms, and whether it reduces OTC/Rx medication use, finding small but significant improvem…
DOI: 10.1159/000531666